The development of GLP-1 RA-specific medical nutrition therapy (MNT) protocols, and the active involvement of an RDN in optimizing key dietary recommendations, including ensuring adequate protein intake (based on g/kg body weight rather than percentage of total energy), increasing fiber intake, and reducing saturated fat intake, is important
This could be to produce another hormone or suppress appetite
But if consumption of sugar does indeed decline thanks to GLP-1 receptor agonist drugs, the industry can continue to reposition as a clean fuels provider
Most long-acting injectable GLP-1 receptor agonists can be administered with or without food there is no requirement to take them on an empty stomach
Improving blood sugar stability, staying hydrated, sleeping well, moving regularly, and reviewing medications with a healthcare provider can help reduce diabetes-related fatigue